55 related articles for article (PubMed ID: 21385859)
1. Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation.
Struijk GH; Gijsen AF; Yong SL; Zwinderman AH; Geerlings SE; Lettinga KD; van Donselaar-van der Pant KA; ten Berge IJ; Bemelman FJ
Nephrol Dial Transplant; 2011 Oct; 26(10):3391-8. PubMed ID: 21385859
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.
Borstnar S; Lindic J; Tomazic J; Kandus A; Pikelj A; Prah J; Skvarc M; Godnov U; Kovac D
Transplant Proc; 2013 May; 45(4):1614-7. PubMed ID: 23726632
[TBL] [Abstract][Full Text] [Related]
3. CMV Infection and Lymphopenia: Warning Markers of
Eberl I; Binquet C; Guilloteau A; Legendre M; Dalle F; Piroth L; Tinel C; Blot M
Transpl Int; 2024; 37():12192. PubMed ID: 38328616
[No Abstract] [Full Text] [Related]
4. Risk of
Cheng YD; Huang CH; Gau SY; Chung NJ; Huang SW; Huang CY; Lee CY
J Fungi (Basel); 2022 Dec; 9(1):. PubMed ID: 36675844
[TBL] [Abstract][Full Text] [Related]
5. Supplementary Role of Immunological Indicators in the Diagnosis and Prognosis of
Cao Y; Chen J; Dong L
Infect Drug Resist; 2022; 15():4675-4683. PubMed ID: 36034170
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of bronchoalveolar lavage fluid analysis in patients with Pneumocystis jirovecii pneumonia without human immunodeficiency virus infection.
Chung C; Lim CM; Oh YM; Hong SB; Choi CM; Huh JW; Lee SW; Lee JS; Jo KW; Ji W; Park CJ; Kim M; Sung H; Cho YU; Cho HS; Kim HC
BMC Pulm Med; 2022 Jun; 22(1):251. PubMed ID: 35754032
[TBL] [Abstract][Full Text] [Related]
7. Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study.
Lee G; Koo TY; Kim HW; Lee DR; Lee DW; Oh J; Kim BS; Kim MS; Yang J;
Sci Rep; 2022 Jun; 12(1):10682. PubMed ID: 35739203
[TBL] [Abstract][Full Text] [Related]
8. Distinct Clinical and Laboratory Patterns of
Meyer AMJ; Sidler D; Hirzel C; Furrer H; Ebner L; Peters AA; Christe A; Huynh-Do U; Walti LN; Arampatzis S
J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947054
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of
Ji J; Wang Q; Huang T; Wang Z; He P; Guo C; Xu W; Cao Y; Dong Z; Wang H
Infect Drug Resist; 2021; 14():4913-4920. PubMed ID: 34853519
[TBL] [Abstract][Full Text] [Related]
10. Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response.
Terrec F; Jouve T; Malvezzi P; Janbon B; Naciri Bennani H; Rostaing L; Noble J
J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768680
[TBL] [Abstract][Full Text] [Related]
11. Single-Center Retrospective Analysis of Prophylaxis and Treatment of Pneumocystis carinii Pneumonia in Patients with Renal Dysfunction After Renal Transplantation.
Pan J; Fu Y; Cao Y; Feng G; Zhao J; Shi X; Mo C; Song W; Shen Z
Ann Transplant; 2020 Nov; 25():e925126. PubMed ID: 33184254
[TBL] [Abstract][Full Text] [Related]
12. Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses.
Betjes MG
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260178
[TBL] [Abstract][Full Text] [Related]
13. A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation.
Betjes MGH; Langerak AW; Klepper M; Litjens NHR
Immun Ageing; 2020; 17():4. PubMed ID: 32082402
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic active antibody-mediated rejection in renal transplant recipients - a single center retrospective study.
Chiu HF; Wen MC; Wu MJ; Chen CH; Yu TM; Chuang YW; Huang ST; Tsai SF; Lo YC; Ho HC; Shu KH
BMC Nephrol; 2020 Jan; 21(1):6. PubMed ID: 31906890
[TBL] [Abstract][Full Text] [Related]
15. Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with
Zhang NN; Huang X; Feng HY; Huang LN; Xia JG; Wang Y; Zhang Y; Wu XJ; Li M; Cui W; Zhan QY
Int J Med Sci; 2019; 16(9):1221-1230. PubMed ID: 31588187
[No Abstract] [Full Text] [Related]
16. m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis.
Ghadimi M; Mohammadpour Z; Dashti-Khavidaki S; Milajerdi A
Eur J Clin Pharmacol; 2019 Nov; 75(11):1471-1480. PubMed ID: 31377892
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
[TBL] [Abstract][Full Text] [Related]
18. Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole used as First-Line Treatment for Pneumocystis jirovecii Pneumonia.
Kim T; Sung H; Chong YP; Kim SH; Choo EJ; Choi SH; Kim TH; Woo JH; Kim YS; Lee SO
Infect Chemother; 2018 Jun; 50(2):110-119. PubMed ID: 29968978
[TBL] [Abstract][Full Text] [Related]
19.
Iriart X; Bouar ML; Kamar N; Berry A
J Fungi (Basel); 2015 Sep; 1(3):293-331. PubMed ID: 29376913
[No Abstract] [Full Text] [Related]
20. Prevalence of
Homayouni MM; Behniafar H; Mehbod ASA; Mohammad-Sadeghi MJ; Maleki B
J Parasit Dis; 2017 Sep; 41(3):850-853. PubMed ID: 28848290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
